Sanofi Genzyme Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Sanofi Genzyme and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 4750 Sanofi Genzyme employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Sanofi Genzyme has purchased the following applications: Veeva Oncology Link for Analytics and BI in 2017, Workday HCM for Core HR in 2010, Veeva CRM for CRM in 2018 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Sanofi Genzyme is running and its propensity to invest more and deepen its relationship with Veeva Systems , Workday , SAP or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Sanofi Genzyme revenues, which have grown to $7.82 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Sanofi Genzyme intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.